FDA to Reverse Ban on Peptides: RFK Jr. Promises Access to Ethical Suppliers
The Food and Drug Administration is set to reverse the ban on certain peptides, as promised by Robert F. Kennedy Jr. The FDA is expected to allow compounding pharmacies to produce peptides for purchase by consumers. Previously, the FDA had concerns about the safety and lack of data on the health impact of peptides.
As per the New York Times, the FDA plans to lift the ban on peptides, which are considered shorter proteins consisting of 2 to 50 amino acids. Further research is needed to understand the benefits and potential side effects of peptides.
The decision to lift the ban on peptides follows RFK Jr.'s commitment to making these peptides available to the public. He highlighted the issue of people resorting to the black market to obtain peptides and aims to address this by providing access to ethical suppliers. RFK Jr. mentioned that specific peptides, around 14 of them, will be made more accessible, although he did not disclose their names.
While acknowledging the need for more research on peptides, RFK Jr. emphasized the importance of making them available to the public. He mentioned that the decision on which peptides to make accessible would be announced in the coming weeks.
In conclusion, the FDA is expected to reverse the ban on certain peptides, allowing compounding pharmacies to produce them for consumer purchase. RFK Jr. aims to provide access to specific peptides through ethical suppliers, despite the need for further research on their benefits and potential side effects.